Treatment of motor and NMS of Parkinson's disease with the rotigotine transdermal system.
Kelly E
KE
Lyons
D000279:Administration, Cutaneous; D018491:Dopamine Agonists / Q000008:administration & dosage*; D006801:Humans; D019957:Motor Skills Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*; D016896:Treatment Outcome
D018491:Dopamine Agonists; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine
Continuous delivery; Dopamine agonist; Parkinson's disease; Rotigotine; Transdermal